de Leon J - Search Results

1

A comprehensive review of the clinical utility of and a combined analysis of the clozapine/norclozapine ratio in therapeutic drug monitoring for adult patients.

Schoretsanitis G, Kane JM, Ruan CJ, Spina E, Hiemke C, de Leon J. Schoretsanitis G, et al. Among authors: de leon j. Expert Rev Clin Pharmacol. 2019 Jul;12(7):603-621. doi: 10.1080/17512433.2019.1617695. Epub 2019 May 31. Expert Rev Clin Pharmacol. 2019. PMID: 31075044

2

Serum antimuscarinic activity during clozapine treatment.

de Leon J, Odom-White A, Josiassen RC, Diaz FJ, Cooper TB, Simpson GM. de Leon J, et al. J Clin Psychopharmacol. 2003 Aug;23(4):336-41. doi: 10.1097/01.jcp.0000085405.08426.73. J Clin Psychopharmacol. 2003. PMID: 12920408 Clinical Trial.

3

Metabolic drug interactions with newer antipsychotics: a comparative review.

Spina E, de Leon J. Spina E, et al. Among authors: de leon j. Basic Clin Pharmacol Toxicol. 2007 Jan;100(1):4-22. doi: 10.1111/j.1742-7843.2007.00017.x. Basic Clin Pharmacol Toxicol. 2007. PMID: 17214606 Free article. Review.

4

Weight gain during a double-blind multidosage clozapine study.

de Leon J, Diaz FJ, Josiassen RC, Cooper TB, Simpson GM. de Leon J, et al. J Clin Psychopharmacol. 2007 Feb;27(1):22-7. doi: 10.1097/JCP.0b013e31802e513a. J Clin Psychopharmacol. 2007. PMID: 17224708 Clinical Trial.

5

Estimating the size of the effects of co-medications on plasma clozapine concentrations using a model that controls for clozapine doses and confounding variables.

Diaz FJ, Santoro V, Spina E, Cogollo M, Rivera TE, Botts S, de Leon J. Diaz FJ, et al. Among authors: de leon j. Pharmacopsychiatry. 2008 May;41(3):81-91. doi: 10.1055/s-2007-1004591. Pharmacopsychiatry. 2008. PMID: 18484549

6

Estimating the effects of co-medications on plasma olanzapine concentrations by using a mixed model.

Botts S, Diaz FJ, Santoro V, Spina E, Muscatello MR, Cogollo M, Castro FE, de Leon J. Botts S, et al. Among authors: de leon j. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1453-8. doi: 10.1016/j.pnpbp.2008.04.018. Epub 2008 May 7. Prog Neuropsychopharmacol Biol Psychiatry. 2008. PMID: 18555573

7

Pharmacokinetic drug interaction studies must consider pharmacological heterogeneity, use of repeated dosing, and translation into a message understandable to practicing clinicians.

de Leon J, Spina E, Diaz FJ. de Leon J, et al. J Clin Psychopharmacol. 2009 Jun;29(3):201-5. doi: 10.1097/JCP.0b013e3181a497f1. J Clin Psychopharmacol. 2009. PMID: 19440070 No abstract available.

8

Short- and long-term effects on prolactin of risperidone and olanzapine treatments in children and adolescents.

Migliardi G, Spina E, D'Arrigo C, Gagliano A, Germanò E, Siracusano R, Diaz FJ, de Leon J. Migliardi G, et al. Among authors: de leon j. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Nov 13;33(8):1496-501. doi: 10.1016/j.pnpbp.2009.08.009. Epub 2009 Aug 23. Prog Neuropsychopharmacol Biol Psychiatry. 2009. PMID: 19706318 Clinical Trial.

9

Effect of valproate on olanzapine plasma concentrations in patients with bipolar or schizoaffective disorder.

Spina E, D'Arrigo C, Santoro V, Muscatello MR, Pandolfo G, Zoccali R, Diaz FJ, de Leon J. Spina E, et al. Among authors: de leon j. Ther Drug Monit. 2009 Dec;31(6):758-63. doi: 10.1097/FTD.0b013e3181c0590e. Ther Drug Monit. 2009. PMID: 19865002

10

Pharmacokinetic drug-drug interactions between olanzapine and valproate need to be better studied.

de Leon J, Diaz FJ, Spina E. de Leon J, et al. J Clin Psychiatry. 2010 Jul;71(7):957-8; author reply 958-9. doi: 10.4088/JCP.09lr05902yel. J Clin Psychiatry. 2010. PMID: 20667295 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

832 results

Search Page

Filters